Analyst Recommendations
Citigroup analyst issues BUY recommendation for CRL on July 8, 2026 10:48AM ET. The previous analyst recommendation was Buy.CRL was trading at $228.68 at issue of the analyst...July 8, 2026 CRL -0.08%
Citigroup analyst issues BUY recommendation for BKR on July 8, 2026 10:45AM ET. The previous analyst recommendation was Buy.BKR was trading at $54.47 at issue of the analyst...July 8, 2026 BKR 0.63%
Citigroup analyst issues BUY recommendation for RIOT on July 8, 2026 10:45AM ET. The previous analyst recommendation was Buy.RIOT was trading at $21.17 at issue of the analyst...July 8, 2026 RIOT -2.51%
Citigroup analyst issues NEUTRAL recommendation for QDEL on July 8, 2026 10:45AM ET. The previous analyst recommendation was Neutral.QDEL was trading at $17 at issue of the analyst...July 8, 2026 QDEL 4.76%
UBS analyst issues NEUTRAL recommendation for WBD on July 8, 2026 10:50AM ET. The previous analyst recommendation was Neutral.WBD was trading at $26.12 at issue of the analyst...July 8, 2026 WBD -0.15%
Morgan Stanley analyst issues OVERWEIGHT recommendation for ROL on July 8, 2026 10:54AM ET. The previous analyst recommendation was Overweight.ROL was trading at $43.62 at issue of the...July 8, 2026 ROL -0.67%
William Blair analyst issues OUTPERFORM recommendation for ZURA on July 8, 2026 10:53AM ET. ZURA was trading at $5.08 at issue of the analyst recommendation.The overall analyst consensus...July 8, 2026 ZURA -7.26%
Wells Fargo analyst issues OVERWEIGHT recommendation for NOC on July 8, 2026 10:55AM ET. The previous analyst recommendation was Overweight.NOC was trading at $549.04 at issue of the...July 8, 2026 NOC 1.39%
Citigroup analyst issues NEUTRAL recommendation for GEHC on July 8, 2026 09:15AM ET. The previous analyst recommendation was Neutral.GEHC was trading at $64.89 at issue of the analyst...July 8, 2026 GEHC 0.00%
Morgan Stanley analyst issues OVERWEIGHT recommendation for IVPAF on July 8, 2026 09:08AM ET. The previous analyst recommendation was Negative.IVPAF was trading at $7.08 at issue of the...July 8, 2026 IVPAF 0.40%